VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy.
Detection of MRD may predict the outcome of patients with Philadelphia chromosome-positive ALL treated with tyrosine kinase inhibitors plus chemotherapy. Blood. 2013 Aug 15; 122(7):1214-21.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Benzamides
Cyclophosphamide
Cytarabine
Dasatinib
Dexamethasone
Doxorubicin
Female
Flow Cytometry
Follow-Up Studies
Fusion Proteins, bcr-abl
Humans
Imatinib Mesylate
Immunoglobulin Heavy Chains
Male
Methotrexate
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Staging
Neoplasm, Residual
Philadelphia Chromosome
Piperazines
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prednisone
Prognosis
Pyrimidines
Real-Time Polymerase Chain Reaction
Remission Induction
Reverse Transcriptase Polymerase Chain Reaction
RNA, Messenger
Survival Rate
Thiazoles
Vincristine
Young Adult
authors with profiles
HAGOP M KANTARJIAN
RICHARD E CHAMPLIN
PARTOW KEBRIAEI
RAJYALAKSHMI LUTHRA
ZEEV ESTROV
JORGE E CORTES
FARHAD RAVANDI-KASHANI
ALESSANDRA FERRAJOLI
XUELIN HUANG
JEFFREY L JORGENSEN
JAN ANDREAS BURGER